Daewon Pharmaceutical Co., Ltd. (KOSE:A003220) announces a share repurchase program. Under the program, the company will repurchase 492,611 shares. The purpose of the program is to stabilize share prices and enhance shareholder value. The repurchase program will continue until June 25, 2020. As of March 23, 2020, the company had 300,938 shares in treasury under the dividend capacity and no shares in treasury under other capacities.